Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
The SARS-CoV-2 coronavirus epidemic has led to an increase in the number of people with depression. Symptoms related to the mental sphere (mainly depression and anxiety) may be experienced by one third of the worldwide population. This entails the need for the effective and rapid treatment of depres...
Enregistré dans:
Auteurs principaux: | Mateusz Kowalczyk, Edward Kowalczyk, Paweł Kwiatkowski, Łukasz Łopusiewicz, Monika Sienkiewicz, Monika Talarowska |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ca4145ee1a4041a6a0c0ffd99daea105 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
par: Muhammad Siddique Kakar, et autres
Publié: (2020) -
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
par: F Kheirkhah, et autres
Publié: (2010) -
Mental Health of PhD Students at Polish Universities—Before the COVID-19 Outbreak
par: Mateusz Kowalczyk, et autres
Publié: (2021) -
<i>N</i>-Methyl-<span style="font-variant: small-caps">d</span>-aspartic Acid (NMDA) Receptor Is Involved in the Inhibitory Effect of Ketamine on Human Sperm Functions
par: Ying Chen, et autres
Publié: (2021) -
Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
par: Vasilescu AN, et autres
Publié: (2017)